Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Collier

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
The New England Journal of Medicine|April 18, 1996
Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials GroupA C Collier, R W Coombs, D A Schoenfeld, et al.
The Journal of Infectious Diseases|August 11, 1998
Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient dataJ P Ioannidis, A C Collier, D A Cooper, et al.
The Clinical Neuropsychologist|June 20, 2012
Defining neurocognitive impairment in HIV: deficit scores versus clinical ratingsK Blackstone, D J Moore, D R Franklin, et al.
The Journal of Infectious Diseases|January 7, 1998
Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapyI C Marschner, A C Collier, R W Coombs, et al.
Journal of Neurovirology|September 18, 2014
Brain morphometric correlates of metabolic variables in HIV: the CHARTER studyS L Archibald, J A McCutchan, C Sanders, et al.
JAMA|April 13, 2001
Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trialA C Collier, L A Kalish, M P Busch, et al.
Journal of the International Neuropsychological Society : JINS|November 26, 2011
Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioningK Blackstone, D J Moore, R K Heaton, et al.
Molecular Neurobiology|September 14, 2018
Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV InfectionA R Kallianpur, H Gittleman, S Letendre, et al.
Journal of Neurovirology|February 15, 2013
Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disordersE E Morgan, S P Woods, S L Letendre, et al.
AIDS (London, England)|September 21, 2000
Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudineD W Haas, E Arathoon, M A Thompson, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
The New England Journal of Medicine|April 18, 1996
Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials GroupA C Collier, R W Coombs, D A Schoenfeld, et al.
The Journal of Infectious Diseases|August 11, 1998
Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient dataJ P Ioannidis, A C Collier, D A Cooper, et al.
The Clinical Neuropsychologist|June 20, 2012
Defining neurocognitive impairment in HIV: deficit scores versus clinical ratingsK Blackstone, D J Moore, D R Franklin, et al.
The Journal of Infectious Diseases|January 7, 1998
Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapyI C Marschner, A C Collier, R W Coombs, et al.
Journal of Neurovirology|September 18, 2014
Brain morphometric correlates of metabolic variables in HIV: the CHARTER studyS L Archibald, J A McCutchan, C Sanders, et al.
JAMA|April 13, 2001
Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trialA C Collier, L A Kalish, M P Busch, et al.
Journal of the International Neuropsychological Society : JINS|November 26, 2011
Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioningK Blackstone, D J Moore, R K Heaton, et al.
Molecular Neurobiology|September 14, 2018
Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV InfectionA R Kallianpur, H Gittleman, S Letendre, et al.
Journal of Neurovirology|February 15, 2013
Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disordersE E Morgan, S P Woods, S L Letendre, et al.
AIDS (London, England)|September 21, 2000
Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudineD W Haas, E Arathoon, M A Thompson, et al.
Pageof 14